ABX
Desconocido
ULTRAPLACAD: ULTRAsensitive PLAsmonic devices for early CAncer Diagnosis
HORIBA ABX SAS
participó en un
H2020:
H2020-PHC-2014-2015
Cancer biomarkers circulating in body fluids have been shown to reflect the pathological process and for this reason can be used for cancer...
2015-04-21 - 2018-10-31 | Financiado
2015-04-21 - 2018-10-31 | Financiado
* No se disponen de datos de la empresa actual.